Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.1038/s41422-021-00504-x
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological inhibition of SRC-1 phase separation suppresses YAP oncogenic transcription activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(26 citation statements)
references
References 13 publications
0
26
0
Order By: Relevance
“…3e ). 141 It is well known that YAP and TAZ are downstream effectors of the Hippo pathway—a tumor suppressor signaling pathway that is important for biological activities such as immune regulation, epithelial homeostasis, and tissue regeneration. 142 Therefore, aberrant YAP/TAZ-mediated transcriptional condensates may contribute to cancer-related pathophysiology.…”
Section: Liquid–liquid Phase Separationmentioning
confidence: 99%
See 1 more Smart Citation
“…3e ). 141 It is well known that YAP and TAZ are downstream effectors of the Hippo pathway—a tumor suppressor signaling pathway that is important for biological activities such as immune regulation, epithelial homeostasis, and tissue regeneration. 142 Therefore, aberrant YAP/TAZ-mediated transcriptional condensates may contribute to cancer-related pathophysiology.…”
Section: Liquid–liquid Phase Separationmentioning
confidence: 99%
“…7h ). 141 Recent research has also shown that allosteric regulators may influence LLPS because allosteric sites in intrinsically disordered proteins can be managed to enhance signaling interactions between various mechanistic components. 299 …”
Section: Prospects Of Applying Llps In Cancer Treatmentmentioning
confidence: 99%
“…At the same time, they also used this phenomenon to inhibit viral RNA replication, which could be used to treat coronaviruses, such as SARS‐CoV‐2. [ 109 ]…”
Section: Drug Development Bases Pathological Phase Separationmentioning
confidence: 99%
“…As mentioned above, aberrant YAP/TAZ-mediated transcriptional condensates may contribute to cancer-related pathophysiology (77)(78)(79). In lung cancer, siRNA library which contains siRNAs for 15 reported histone acetylation transferase (HAT) was used to perform a screening assay (121). Then it was found that YAP can further form YAP/TEAD/SRC-1 complexes by interacting with SRC-1 and extensively improve YAP transcriptional activity.…”
Section: Src1 In Lung Cancermentioning
confidence: 99%
“…Mechanistically, EVG can effectively inhibits the development of the SRC-1/YAP/TEAD complex formation to restrict tumor growth in a YAP-dependent manner by specifically targeting LLPS of SRC-1. Gene expression profiling revealed that EVG suppressed the expression of YAP target genes in lung cancer ( 121 ).…”
Section: Targeting Llps Is a Promising Therapeutic Strategy For Treat...mentioning
confidence: 99%